Literature DB >> 20387306

Correlating familial Alzheimer's disease gene mutations with clinical phenotype.

Natalie S Ryan1, Martin N Rossor.   

Abstract

Alzheimer's disease (AD) causes devastating cognitive impairment and an intense research effort is currently devoted to developing improved treatments for it. A minority of cases occur at a particularly young age and are caused by autosomal dominantly inherited genetic mutations. Although rare, familial AD provides unique opportunities to gain insights into the cascade of pathological events and how they relate to clinical manifestations. The phenotype of familial AD is highly variable and, although it shares many clinical features with sporadic AD, it also possesses important differences. Exploring the genetic and pathological basis of this phenotypic heterogeneity can illuminate aspects of the underlying disease mechanism, and is likely to inform our understanding and treatment of AD in the future.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20387306      PMCID: PMC3937872          DOI: 10.2217/bmm.09.92

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  81 in total

1.  Ataxic variant of Alzheimer's disease caused by Pro117Ala PSEN1 mutation.

Authors:  M Anheim; D Hannequin; C Boulay; C Martin; D Campion; C Tranchant
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-12       Impact factor: 10.154

2.  Two novel presenilin 1 gene mutations connected with frontotemporal dementia-like clinical phenotype: genetic and bioinformatic assessment.

Authors:  Cezary Zekanowski; Maciej P Golan; Krystiana A Krzyśko; Wanda Lipczyńska-Łojkowska; Sławomir Filipek; Anna Kowalska; Grzegorz Rossa; Beata Pepłońska; Maria Styczyńska; Aleksandra Maruszak; Dorota Religa; Mieczysław Wender; Jerzy Kulczycki; Maria Barcikowska; Jacek Kuźnicki
Journal:  Exp Neurol       Date:  2006-03-20       Impact factor: 5.330

3.  Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer disease.

Authors:  Hans Basun; Nenad Bogdanovic; Martin Ingelsson; Ove Almkvist; Jan Näslund; Karin Axelman; Thomas D Bird; David Nochlin; Gerard D Schellenberg; Lars-Olof Wahlund; Lars Lannfelt
Journal:  Arch Neurol       Date:  2008-04

Review 4.  A two decade contribution of molecular cell biology to the centennial of Alzheimer's disease: are we progressing toward therapy?

Authors:  Katleen Dillen; Wim Annaert
Journal:  Int Rev Cytol       Date:  2006

Review 5.  Variable phenotype of Alzheimer's disease with spastic paraparesis.

Authors:  Helena Karlstrom; William S Brooks; John B J Kwok; G Anthony Broe; Jillian J Kril; Heather McCann; Glenda M Halliday; Peter R Schofield
Journal:  J Neurochem       Date:  2007-11-06       Impact factor: 5.372

6.  Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype.

Authors:  James B Leverenz; Mark A Fishel; Elaine R Peskind; Thomas J Montine; David Nochlin; Ellen Steinbart; Murray A Raskind; Gerard D Schellenberg; Thomas D Bird; Debby Tsuang
Journal:  Arch Neurol       Date:  2006-03

7.  Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype.

Authors:  Alessandra Piccini; Gianluigi Zanusso; Roberta Borghi; Cristiana Noviello; Salvatore Monaco; Roberta Russo; Gianluca Damonte; Andrea Armirotti; Matteo Gelati; Renzo Giordano; Pamela Zambenedetti; Claudio Russo; Bernardino Ghetti; Massimo Tabaton
Journal:  Arch Neurol       Date:  2007-05

8.  Apolipoprotein e genotype modifies the phenotype of Alzheimer disease.

Authors:  Jonathan M Schott; Basil H Ridha; Sebastian J Crutch; Daniel G Healy; James B Uphill; Elizabeth K Warrington; Martin N Rossor; Nick C Fox
Journal:  Arch Neurol       Date:  2006-01

Review 9.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.

Authors:  A J Larner; M Doran
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 6.682

10.  Mutations in progranulin explain atypical phenotypes with variants in MAPT.

Authors:  Stuart M Pickering-Brown; Matt Baker; Jenny Gass; Bradley F Boeve; Clement T Loy; William S Brooks; Ian R A Mackenzie; Ralph N Martins; John B J Kwok; Glenda M Halliday; Jillian Kril; Peter R Schofield; David M A Mann; Mike Hutton
Journal:  Brain       Date:  2006-11       Impact factor: 13.501

View more
  56 in total

1.  Heritability in frontotemporal dementia: more missing pieces?

Authors:  Kieren Po; Felicity V C Leslie; Natalie Gracia; Lauren Bartley; John B J Kwok; Glenda M Halliday; John R Hodges; James R Burrell
Journal:  J Neurol       Date:  2014-08-26       Impact factor: 4.849

2.  Cerebral microbleeds in familial Alzheimer's disease.

Authors:  Natalie S Ryan; António J Bastos-Leite; Jonathan D Rohrer; David J Werring; Nick C Fox; Martin N Rossor; Jonathan M Schott
Journal:  Brain       Date:  2011-06-17       Impact factor: 13.501

3.  Forgetful and robotic: tap on a gene!

Authors:  Lucio Tremolizzo; E Susani; D Binda; F Bertola; C Ferrarese; I Appollonio
Journal:  Neurol Sci       Date:  2015-01-08       Impact factor: 3.307

4.  Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging study.

Authors:  Kirsi M Kinnunen; David M Cash; Teresa Poole; Chris Frost; Tammie L S Benzinger; R Laila Ahsan; Kelvin K Leung; M Jorge Cardoso; Marc Modat; Ian B Malone; John C Morris; Randall J Bateman; Daniel S Marcus; Alison Goate; Stephen P Salloway; Stephen Correia; Reisa A Sperling; Jasmeer P Chhatwal; Richard P Mayeux; Adam M Brickman; Ralph N Martins; Martin R Farlow; Bernardino Ghetti; Andrew J Saykin; Clifford R Jack; Peter R Schofield; Eric McDade; Michael W Weiner; John M Ringman; Paul M Thompson; Colin L Masters; Christopher C Rowe; Martin N Rossor; Sebastien Ourselin; Nick C Fox
Journal:  Alzheimers Dement       Date:  2017-07-22       Impact factor: 21.566

5.  Functional connectivity in autosomal dominant and late-onset Alzheimer disease.

Authors:  Jewell B Thomas; Matthew R Brier; Randall J Bateman; Abraham Z Snyder; Tammie L Benzinger; Chengjie Xiong; Marcus Raichle; David M Holtzman; Reisa A Sperling; Richard Mayeux; Bernardino Ghetti; John M Ringman; Stephen Salloway; Eric McDade; Martin N Rossor; Sebastien Ourselin; Peter R Schofield; Colin L Masters; Ralph N Martins; Michael W Weiner; Paul M Thompson; Nick C Fox; Robert A Koeppe; Clifford R Jack; Chester A Mathis; Angela Oliver; Tyler M Blazey; Krista Moulder; Virginia Buckles; Russ Hornbeck; Jasmeer Chhatwal; Aaron P Schultz; Alison M Goate; Anne M Fagan; Nigel J Cairns; Daniel S Marcus; John C Morris; Beau M Ances
Journal:  JAMA Neurol       Date:  2014-09       Impact factor: 18.302

6.  Familial Alzheimer's disease-associated presenilin-1 alters cerebellar activity and calcium homeostasis.

Authors:  Diego Sepulveda-Falla; Alvaro Barrera-Ocampo; Christian Hagel; Anne Korwitz; Maria Fernanda Vinueza-Veloz; Kuikui Zhou; Martijn Schonewille; Haibo Zhou; Luis Velazquez-Perez; Roberto Rodriguez-Labrada; Andres Villegas; Isidro Ferrer; Francisco Lopera; Thomas Langer; Chris I De Zeeuw; Markus Glatzel
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

Review 7.  Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies.

Authors:  Chao Peng; Ronald J Gathagan; Virginia M-Y Lee
Journal:  Neurobiol Dis       Date:  2017-07-24       Impact factor: 5.996

Review 8.  Biomarker modelling of early molecular changes in Alzheimer's disease.

Authors:  Ross W Paterson; Jamie Toombs; Catherine F Slattery; Jonathan M Schott; Henrik Zetterberg
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

9.  Subjects harboring presenilin familial Alzheimer's disease mutations exhibit diverse white matter biochemistry alterations.

Authors:  Alex E Roher; Chera L Maarouf; Michael Malek-Ahmadi; Jeffrey Wilson; Tyler A Kokjohn; Ian D Daugs; Charisse M Whiteside; Walter M Kalback; Mimi P Macias; Sandra A Jacobson; Marwan N Sabbagh; Bernardino Ghetti; Thomas G Beach
Journal:  Am J Neurodegener Dis       Date:  2013-09-18

Review 10.  Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease.

Authors:  S Hunter; C Brayne
Journal:  Mol Psychiatry       Date:  2017-11-07       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.